Is a complete ZYBT research report available?

No complete published report is available for Zhengye Biotechnology Holding Limited (ZYBT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ: ZYBT · USD

$1.23

-0.10 (-7.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ZYBT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	58.3M
Revenue (ttm)	16.6M
Net income (ttm)	-10M
EPS (ttm)	-$0.21
Shares out	47.4M
Volume	310,779

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.6M
Net income (ttm): -10M
EPS (ttm): -$0.21
Market cap: 58.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ZYBT indicators

Market & fundamental data

Available fields

200

Groups with data

Currency

CNY

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001975641
Company name	Zhengye Biotechnology Holding Limited
Country	China
Country code	US
Cusip	G989MS101
Employees	269
Employees Change	-8%
Employees Change Percent	-2.89
Enterprise value	$59.7M
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	90.42
Industry PE Fwd	14.46
IPO Date	2025-01-07
Isin	KYG989MS1016
Last refreshed	2026-07-30
Market cap	$58.3M
Market cap category	Micro-Cap
Price	$1.23
Price currency	USD
Rev Per Employee	61,845.55x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	ZYBT
Website	https://www.jlzybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.69%
EV/FCF	32.8x
EV/Sales	3.59x
FCF yield	3.23%
P/B ratio	1.76x
P/S ratio	3.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-60.59%
EBITDA Margin	-38.35%
FCF margin	10.59%
Gross margin	20.51%
Gross Profit	$3.4M
Gross Profit Growth	-73.86%
Gross Profit Growth Q	-90.99%
Gross Profit Growth3 Y	-45.55%
Net Income	$-10M
Net Income Growth Years	0%
Pretax Margin	-61.77%
Profit Margin	-59.97%
Profit Per Employee	$-37,090
ROA	-9.48
ROCE	-23.05
ROE	-25.17
ROIC	-21.37
Roic5y	4.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-78.63%
EPS Growth Years	0
FCF Growth	-55.12%
FCF Growth Q	82.72%
OCF Growth	-67.52%
OCF Growth Q	3.58%
OCF Growth3 Y	-8.38%
Revenue Growth	-37.56x
Revenue Growth Q	-40.89x
Revenue Growth Years	0x
Revenue Growth3 Y	-23.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.25
Assets	$62.4M
Cash	$7.4M
Current Assets	$20.3M
Current Liabilities	$17.8M
Debt	$10.7M
Debt Equity	$0.24
Debt FCF	$5.9
Equity	$43.9M
Interest Coverage	-21.42
Liabilities	$18.6M
Long Term Assets	$42.1M
Long Term Liabilities	$757,302
Net Cash	$-3.3M
Net Cash By Market Cap	$-5.88
Net Debt Equity	$0.08
Net Debt FCF	$1.82
Tangible Book Value	$27.9M
Tangible Book Value Per Share	$0.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	1.9
Net Working Capital	$4.4M
Quick ratio	0.58
Working Capital	$2.4M
Working Capital Turnover	$0.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-78.61%
200-day SMA	1.32
50-day SMA	1.06
50-day SMA vs 200-day SMA	50under200
All Time High	14.3
All Time High Change	-91.4%
All Time High Date	2025-04-29
All Time Low	0.62
All Time Low Change	99.84%
All Time Low Date	2026-07-02
ATR	0.79
Beta1y	0.53
Beta2y	-0.69
Ch YTD	6.96
High	1.29
High52	13.08
High52 Date	2025-09-02
High52ch	-90.6%
Low	1.17
Low52	0.62
Low52 Date	2026-07-02
Low52ch	99.84%
Ma50ch	15.6%
Premarket Change Percent	-5.26
Premarket Price	$1.26
Premarket Volume	40,562
Price vs 200-day SMA	-6.68%
RSI	49.05
RSI Monthly	43.37
RSI Weekly	49.79
Sharpe ratio	0.78x
Sortino ratio	6.2
Total Return	-3.69%
Tr YTD	6.96
Tr1m	72.41%
Tr1w	-10.87%
Tr3m	33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-10.1M
Operating margin	-60.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,261,744%
Float Percent	13.21%
Net Borrowing	-1,807,842.8
Shares Institutions	0.31%
Shares Out	47,391,376
Shares Qo Q	0.14%
Shares Yo Y	3.69%
Short Float	0.92%
Short Ratio	0.9
Short Shares	0.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	11,704,967.1x
Bv Per Share	0.75
CAPEX	$-148,881
Ch1m	72.41
Ch1w	-10.87
Ch1y	-78.61
Ch3m	33.33
Ch6m	23
Change	-7.52%
Change From Open	-1.6
Close	1.33
Days Gap	-6.02
Depreciation Amortization	3,822,908.2
Dollar Volume	382,258.2
Earnings Date	2026-04-28
Earnings Time	amc
EBIT	$-10.4M
EBITDA	$-6.6M
EPS	$-0.21
F Score	2
FCF	$1.8M
FCF EV Yield	3.05x
FCF Per Share	$0.04
Financing CF	4,619,410
Fiscal Year End	December
Founded	2,004
Income Tax	$1.6M
Investing CF	-1,805,730
Ipr	-70.25
Iprfo	-68.44
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-28
Ma150	1.01
Ma150ch	21.9%
Ma20	1.43
Ma20ch	-14.05%
Net CF	4,536,200
Next Earnings Date	2026-12-11
Open	1.25
Optionable	No
P FCF Ratio	30.98
P OCF Ratio	28.64
Position In Range	50
Post Close	1.23
Postmarket Change Percent	-5.69
Postmarket Price	$1.16
Ppne	35,046,303.8
Pre Close	1.33
Price Date	2026-07-29
Ptbv Ratio	2.02
Relative Volume	0.03x
Revenue	16,636,452x
Tax By Revenue	9.53x
Tr6m	23%
Volume	310,779
Z Score	8.39

Zhengye Biotechnology Holding Limited (ZYBT)

Coverage state: Market snapshot only — no published research

Generate the first ZYBT analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ZYBT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZYBT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ZYBT

Frequently asked questions